Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;26(21):2100433.
doi: 10.2807/1560-7917.ES.2021.26.21.2100433.

SARS-CoV-2 variant B.1.1.7 susceptibility and infectiousness of children and adults deduced from investigations of childcare centre outbreaks, Germany, 2021

Affiliations

SARS-CoV-2 variant B.1.1.7 susceptibility and infectiousness of children and adults deduced from investigations of childcare centre outbreaks, Germany, 2021

Anna Loenenbach et al. Euro Surveill. 2021 May.

Abstract

We investigated three SARS-CoV-2 variant B.1.1.7 childcare centre and related household outbreaks. Despite group cohorting, cases occurred in almost all groups, i.e. also among persons without close contact. Children's secondary attack rates (SAR) were similar to adults (childcare centres: 23% vs 30%; p = 0.15; households: 32% vs 39%; p = 0.27); child- and adult-induced household outbreaks also led to similar SAR. With the advent of B.1.1.7, susceptibility and infectiousness of children and adults seem to converge. Public health measures should be revisited accordingly.

Keywords: B.1.1.7; COVID-19; SARS-CoV-2; VOC; childcare centre; infectiousness; kindergarten; outbreak; secondary attack rate; susceptibility.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

References

    1. Robert Koch-Institut (RKI). Bericht zu Virusvarianten von SARS-CoV-2 in Deutschland, insbesondere zur Variant of Concern (VOC) B.1.1.7, Stand 03.März 2021. [Report about variants of SARS-CoV-2 in Germany, particularly the variant of concern (VOC) B.1.1.7, status: 3 March 2021]. Berlin: RKI. [Accessed: 12 Mar 2021]. German. Available from: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/DESH/Berich...
    1. Davies NG, Barnard RC, Jarvis CI, Kucharski AJ, Munday J, Pearson CAB, et al. Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England. medRxiv. 20 Dec 2020. 10.1101/2020.12.24.20248822 - DOI
    1. Walker AS, Vihta K-D, Gethings O, Pritchard E, Jones J, House T, et al. Increased infections, but not viral burden, with a new SARS-CoV-2 variant. medRxiv. 15 Jan 2021. 10.1101/2021.01.13.21249721 - DOI
    1. Graham MS, Sudre CH, May A, Antonelli M, Murray B, Varsavsky T, et al. The effect of SARS-CoV-2 variant B.1.1.7 on symptomatology, re-infection and transmissibility. medRxiv. 29 Jan 2021. 10.1101/2021.01.28.21250680 - DOI
    1. Public Health England (PHE). Investigation of novel SARS-CoV-2 variant - Variant of Concern 202012/01 - Technical briefing 3. London: PHE. [Accessed: 15 May 2021]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploa...

LinkOut - more resources